XML 45 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCKHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
STOCKHOLDERS' EQUITY

13.   STOCKHOLDERS’ EQUITY

Common Stock Offering

On February 2, 2021, the Company closed on their secondary public offering and sale (the “Offering”) of their common stock in which the Company issued and sold 5,566,000 shares of our common stock, which included shares pursuant to an option granted to underwriters to purchase additional shares, at a public offering price of $15.50 per share. The Company received net proceeds of $80.6 million after deducting underwriting discounts, commissions and offering expenses.

Common Stock

The Company’s amended and restated certificate of incorporation as of December 31, 2020 authorized the issuance of 200.0 million shares of common stock, $0.01 par value per share, of which 29.1 million were issued and outstanding as of December 31, 2023.

The following table summarizes the total number of shares of the Company’s common stock issued and reserved for issuance as of December 31, 2023 and 2022 (in thousands):

​

​

​

​

​

​

​

​

    

December 31, 2023

    

December 31, 2022

​

Shares of common stock issued

 

29,092

 

27,268

​

Shares of common stock reserved for issuance for:

 

  

 

  

​

Common stock warrants outstanding

 

41

 

61

​

Stock options outstanding

 

1,270

 

1,301

​

Restricted stock units outstanding

 

3,360

 

3,901

​

Shares available for grant under stock incentive plans

 

978

 

1,140

​

Shares available for sale under employee stock purchase plan

 

1,335

 

1,063

​

Total shares of common stock issued and reserved for issuance

 

36,076

 

34,734

​

​

Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders. Holders of common stock are entitled to receive any dividends that the Company’s board of directors may declare out of funds legally available for that purpose on a non-cumulative basis. The Company has never paid, and for the foreseeable future does not expect to pay, a dividend on its common stock.

Common Stock Warrants

The following table summarizes the Company’s outstanding common stock warrants as of December 31, 2023 and 2022 (in thousands):

​

​

​

​

​

​

​

December 31, 2023

    

    

​

    

    

Warrants

    

    

​

    

    

Outstanding

​

​

​

​

​

(in thousands)

​

Exercise Price

​

Expiration Date

20

​

$

9.73

 

Mar-2024

21

​

$

9.73

 

Dec-2024

41

​

 

  

 

  

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2022

    

    

​

    

    

Warrants

    

    

​

    

    

Outstanding

​

​

​

​

​

(in thousands)

​

Exercise Price

​

Expiration Date

20

​

$

9.73

 

Aug-2023

20

​

$

9.73

 

Mar-2024

21

​

$

9.73

 

Dec-2024

61

​

 

  

 

  

​